| Year |
Citation |
Score |
| 2023 |
Toyonaga T, Khattar N, Wu Y, Lu Y, Naganawa M, Gallezot JD, Matuskey D, Mecca AP, Pittman B, Dias M, Nabulsi NB, Finnema SJ, Chen MK, Arnsten A, Radhakrishnan R, et al. The regional pattern of age-related synaptic loss in the human brain differs from gray matter volume loss: in vivo PET measurement with [C]UCB-J. European Journal of Nuclear Medicine and Molecular Imaging. PMID 37955791 DOI: 10.1007/s00259-023-06487-8 |
0.676 |
|
| 2022 |
Radhakrishnan R, Worhunsky PD, Zheng MQ, Najafzadeh S, Gallezot JD, Planeta B, Henry S, Nabulsi N, Ranganathan M, Skosnik PD, Pittman B, Cyril D'Souza D, Carson RE, Huang Y, Potenza MN, et al. Age, gender and body-mass-index relationships with in vivo CB receptor availability in healthy humans measured with [C]OMAR PET. Neuroimage. 264: 119674. PMID 36243269 DOI: 10.1016/j.neuroimage.2022.119674 |
0.582 |
|
| 2022 |
Radhakrishnan R, Guloksuz S, D'Souza DC, van Os J. Editorial: Gone to Pot: Examining the Association Between Cannabis Use and Medical/Psychiatric Disorders. Frontiers in Psychiatry. 13: 837757. PMID 35211046 DOI: 10.3389/fpsyt.2022.837757 |
0.492 |
|
| 2021 |
Angarita GA, Worhunsky PD, Naganawa M, Toyonaga T, Nabulsi NB, Li CR, Esterlis I, Skosnik PD, Radhakrishnan R, Pittman B, Gueorguieva R, Potenza MN, Finnema SJ, Huang Y, Carson RE, et al. Lower prefrontal cortical synaptic vesicle binding in cocaine use disorder: An exploratory C-UCB-J positron emission tomography study in humans. Addiction Biology. e13123. PMID 34852401 DOI: 10.1111/adb.13123 |
0.585 |
|
| 2021 |
Radhakrishnan R, Skosnik PD, Ranganathan M, Naganawa M, Toyonaga T, Finnema S, Hillmer AT, Esterlis I, Huang Y, Nabulsi N, Carson RE, D'Souza DC. In vivo evidence of lower synaptic vesicle density in schizophrenia. Molecular Psychiatry. PMID 34135473 DOI: 10.1038/s41380-021-01184-0 |
0.695 |
|
| 2021 |
Radhakrishnan R, Ranganathan M, Skosnik PD, D'Souza DC. Exocannabinoids, Endocannabinoids, and Psychosis. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 6: 600-602. PMID 34099185 DOI: 10.1016/j.bpsc.2021.04.012 |
0.7 |
|
| 2021 |
Fang XT, Toyonaga T, Hillmer AT, Matuskey D, Holmes SE, Radhakrishnan R, Mecca AP, van Dyck CH, D'Souza DC, Esterlis I, Worhunsky PD, Carson RE. Identifying brain networks in synaptic density PET (C-UCB-J) with independent component analysis. Neuroimage. 118167. PMID 34000404 DOI: 10.1016/j.neuroimage.2021.118167 |
0.487 |
|
| 2021 |
Ranganathan M, Rahman M, Ganesh S, D'Souza DC, Skosnik PD, Radhakrishnan R, Pathania S, Mohanakumar T. Analysis of Circulating Exosomes Reveals a Peripheral Signature of Astrocytic Pathology in Schizophrenia. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-31. PMID 33821753 DOI: 10.1080/15622975.2021.1907720 |
0.704 |
|
| 2020 |
D'Souza DC, Radhakrishnan R, Naganawa M, Ganesh S, Nabulsi N, Najafzadeh S, Ropchan J, Ranganathan M, Cortes-Briones J, Huang Y, Carson RE, Skosnik P. Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorder. Molecular Psychiatry. PMID 32973170 DOI: 10.1038/s41380-020-00891-4 |
0.7 |
|
| 2020 |
Ganesh S, Cortes-Briones J, Ranganathan M, Radhakrishnan R, Skosnik PD, D'Souza DC. Psychosis-relevant effects of intravenous delta-9-tetrahydrocannabinol - A mega analysis of individual participant-data from human laboratory studies. The International Journal of Neuropsychopharmacology. PMID 32385508 DOI: 10.1093/Ijnp/Pyaa031 |
0.692 |
|
| 2020 |
Hindley G, Beck K, Borgan F, Ginestet CE, McCutcheon R, Kleinloog D, Ganesh S, Radhakrishnan R, D'Souza DC, Howes OD. Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis. The Lancet. Psychiatry. PMID 32197092 DOI: 10.1016/S2215-0366(20)30074-2 |
0.566 |
|
| 2019 |
Radhakrishnan R, Matuskey D, Nabulsi N, Gaiser E, Gallezot JD, Henry S, Planeta B, Lin SF, Ropchan J, Huang Y, Carson RE, D'Souza DC. In vivo 5-HT and 5-HT receptor availability in antipsychotic treated schizophrenia patients vs. unmedicated healthy humans measured with [C]GSK215083 PET. Psychiatry Research. Neuroimaging. 295: 111007. PMID 31760336 DOI: 10.1016/J.Pscychresns.2019.111007 |
0.546 |
|
| 2019 |
Pradeep JR, Acharya MS, Radhakrishnan R, Srinivasan K. Elevated Unconjugated Bilirubin in Schizophrenia Compared to Bipolar Affective Disorder. The Primary Care Companion For Cns Disorders. 21. PMID 31364826 DOI: 10.4088/Pcc.19M02448 |
0.373 |
|
| 2019 |
Ranganathan M, De Aquino JP, Cortes-Briones JA, Radhakrishnan R, Pittman B, Bhakta S, D'Souza DC. Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans. Psychopharmacology. PMID 31187152 DOI: 10.1007/S00213-019-05273-5 |
0.51 |
|
| 2019 |
Radhakrishnan R, Ranganathan M, D'Souza DC. Medical Marijuana: What Physicians Need to Know. The Journal of Clinical Psychiatry. 80. PMID 31087827 DOI: 10.4088/Jcp.18Ac12537 |
0.478 |
|
| 2019 |
Orr C, Spechler P, Cao Z, Albaugh M, Chaarani B, Mackey S, D'Souza D, Allgaier N, Banaschewski T, Bokde ALW, Bromberg U, Büchel C, Burke Quinlan E, Conrod P, Desrivières S, ... ... Radhakrishnan R, et al. Grey Matter Volume Differences Associated with Extremely Low Levels of Cannabis Use in Adolescence. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30643026 DOI: 10.1523/Jneurosci.3375-17.2018 |
0.559 |
|
| 2019 |
Radhakrishnan R. 20. Elucidating The Link Between Cannabis Use And Psychosis: From The Exposome And Phenome To The Epigenome And Receptome Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz022.079 |
0.323 |
|
| 2019 |
Radhakrishnan R, Skosnik P, Ranganathan M, Naganawa M, Finnema S, Esterlis I, Huang Y, Nabulsi N, Carson R, D’Souza D. S13. IN VIVO EVIDENCE OF REDUCED SYNAPTIC VESICLE DENSITY IN SCHIZOPHRENIA USING [11C] UCB-J PET IMAGING Schizophrenia Bulletin. 45: S310-S311. DOI: 10.1093/Schbul/Sbz020.558 |
0.648 |
|
| 2018 |
D'Souza DC, Cortes-Briones J, Creatura G, Bluez G, Thurnauer H, Deaso E, Bielen K, Surti T, Radhakrishnan R, Gupta A, Gupta S, Cahill J, Sherif MA, Makriyannis A, Morgan PT, et al. Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial. The Lancet. Psychiatry. PMID 30528676 DOI: 10.1016/S2215-0366(18)30427-9 |
0.687 |
|
| 2018 |
Pries LK, Guloksuz S, Ten Have M, de Graaf R, van Dorsselaer S, Gunther N, Rauschenberg C, Reininghaus U, Radhakrishnan R, Bak M, Rutten BPF, van Os J. Evidence That Environmental and Familial Risks for Psychosis Additively Impact a Multidimensional Subthreshold Psychosis Syndrome. Schizophrenia Bulletin. PMID 29701807 DOI: 10.1093/Schbul/Sby051 |
0.302 |
|
| 2018 |
De Aquino JP, Sherif M, Radhakrishnan R, Cahill JD, Ranganathan M, D'Souza DC. The Psychiatric Consequences of Cannabinoids. Clinical Therapeutics. PMID 29678279 DOI: 10.1016/J.Clinthera.2018.03.013 |
0.579 |
|
| 2018 |
Radhakrishnan R, Nabulsi N, Gaiser E, Gallezot JD, Henry S, Planeta B, Lin SF, Ropchan J, Williams W, Morris E, D'Souza DC, Huang Y, Carson RE, Matuskey D. Age-related change in 5-HT6 receptor availability in healthy male volunteers measured withC-GSK215083 PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29626125 DOI: 10.2967/Jnumed.117.206516 |
0.524 |
|
| 2017 |
Radhakrishnan R, Kaser M, Guloksuz S. The Link Between the Immune System, Environment, and Psychosis. Schizophrenia Bulletin. 43: 693-697. PMID 28969353 DOI: 10.1093/Schbul/Sbx057 |
0.318 |
|
| 2017 |
Ranganathan M, Radhakrishnan R, Addy PH, Schnakenberg A, Williams A, Carbuto M, Elander J, Pittman B, Andrew Sewell R, Skosnik PD, D'Souza DC. Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 28642081 DOI: 10.1016/J.Pnpbp.2017.06.019 |
0.692 |
|
| 2017 |
Radhakrishnan R, Skosnik P, Finnema S, Rotolo R, Forselius-Bielen K, Creatura G, Nabulsi N, Carson R, D׳Souza D. 962. In-vivo Evidence of Decreased Synaptic Density in Schizophrenia: A [11C]UCB-J PET Imaging Study Biological Psychiatry. 81: S389. DOI: 10.1016/J.Biopsych.2017.02.688 |
0.65 |
|
| 2016 |
D Souza DC, Radhakrishnan R, Sherif M, Cortes-Briones J, Cahill J, Gupta S, Skosnik PD, Ranganathan M. Cannabinoids and Psychosis. Current Pharmaceutical Design. PMID 27568729 DOI: 10.2174/1381612822666160826105628 |
0.657 |
|
| 2016 |
Wilkinson ST, Radhakrishnan R, D'Souza DC. A Systematic Review of the Evidence for Medical Marijuana in Psychiatric Indications. The Journal of Clinical Psychiatry. 77: 1050-64. PMID 27561138 DOI: 10.4088/Jcp.15R10036 |
0.535 |
|
| 2016 |
Sherif M, Radhakrishnan R, D'Souza DC, Ranganathan M. Human Laboratory Studies on Cannabinoids and Psychosis. Biological Psychiatry. 79: 526-38. PMID 26970363 DOI: 10.1016/J.Biopsych.2016.01.011 |
0.604 |
|
| 2015 |
Wilkinson ST, Yarnell S, Radhakrishnan R, Ball SA, D'Souza DC. Marijuana Legalization: Impact on Physicians and Public Health. Annual Review of Medicine. PMID 26515984 DOI: 10.1146/Annurev-Med-050214-013454 |
0.526 |
|
| 2015 |
Ranganathan M, Cortes-Briones J, Radhakrishnan R, Thurnauer H, Planeta B, Skosnik P, Gao H, Labaree D, Neumeister A, Pittman B, Surti T, Huang Y, Carson RE, D'Souza DC. Reduced Brain Cannabinoid Receptor Availability In Schizophrenia. Biological Psychiatry. PMID 26432420 DOI: 10.1016/J.Biopsych.2015.08.021 |
0.722 |
|
| 2015 |
Radhakrishnan R, Kiluk BD, Tsai J. A Meta-analytic Review of Non-specific Effects in Randomized Controlled Trials of Cognitive Remediation for Schizophrenia. The Psychiatric Quarterly. PMID 25952944 DOI: 10.1007/S11126-015-9362-6 |
0.314 |
|
| 2015 |
Radhakrishnan R, Skosnik PD, Cortes-Briones J, Sewell RA, Carbuto M, Schnakenberg A, Cahill J, Bois F, Gunduz-Bruce H, Pittman B, Ranganathan M, D'Souza DC. GABA Deficits Enhance the Psychotomimetic Effects of Δ(9)-THC. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 2047-56. PMID 25728472 DOI: 10.1038/Npp.2015.58 |
0.706 |
|
| 2014 |
Wilkinson ST, Radhakrishnan R, D'Souza DC. Impact of Cannabis Use on the Development of Psychotic Disorders. Current Addiction Reports. 1: 115-128. PMID 25767748 DOI: 10.1007/S40429-014-0018-7 |
0.595 |
|
| 2014 |
Radhakrishnan R, Wilkinson ST, D'Souza DC. Gone to Pot - A Review of the Association between Cannabis and Psychosis. Frontiers in Psychiatry. 5: 54. PMID 24904437 DOI: 10.3389/Fpsyt.2014.00054 |
0.613 |
|
| 2014 |
Ranganathan M, Sewell RA, Carbuto M, Elander J, Schnakenberg A, Radhakrishnan R, Pittman B, D'Souza DC. Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism. Psychopharmacology. 231: 2385-93. PMID 24424782 DOI: 10.1007/S00213-013-3402-4 |
0.498 |
|
| 2014 |
D'Souza DC, Ranganathan M, Addy P, Thurnauer H, Schnakenberg A, Pittman B, Radhakrishnan R, Skosnik P, Andrew Sewell R. Poster #T56 LEARN BEFORE YOU BURN: THC IMPAIRS ENCODING BUT NOT RETRIEVAL OF VERBAL INFORMATION Schizophrenia Research. 153: S308-S309. DOI: 10.1016/S0920-9964(14)70873-4 |
0.661 |
|
| 2014 |
D'Souza DC, Cortes J, Ranganathan M, Thurnauer H, Planeta B, Radhakrishnan R, Huang Y, Carson R, Skosnik P. Poster #S268 DECREASED BRAIN CANNABINOID RECEPTOR (CB1R) AVAILABILITY IN CANNABIS DEPENDENCE RAPIDLY NORMALIZES WITH ABSTINENCE Schizophrenia Research. 153: S187. DOI: 10.1016/S0920-9964(14)70547-X |
0.686 |
|
| 2014 |
D'Souza DC, Thurnauer H, Ranganathan M, Cortes J, Radhakrishnan R, Carson R, Huang YH, Planeta-Wilson B. 5:30 PM IN VIVO EVIDENCE OF REDUCED BRAIN CANNABINOID RECEPTORS IN SCHIZOPHRENIA Schizophrenia Research. 153: S52. DOI: 10.1016/S0920-9964(14)70171-9 |
0.587 |
|
| 2013 |
Cortes JA, Radhakrishnan R. A case of amelioration of venlafaxine-discontinuation "brain shivers" with atomoxetine. The Primary Care Companion For Cns Disorders. 15. PMID 23930231 DOI: 10.4088/Pcc.12L01427 |
0.305 |
|
| 2013 |
Sewell RA, Schnakenberg A, Elander J, Radhakrishnan R, Williams A, Skosnik PD, Pittman B, Ranganathan M, D'Souza DC. Acute effects of THC on time perception in frequent and infrequent cannabis users. Psychopharmacology. 226: 401-13. PMID 23179965 DOI: 10.1007/S00213-012-2915-6 |
0.681 |
|
| 2013 |
D'Souza DC, Radhakrishnan R, Perry E, Bhakta S, Singh NM, Yadav R, Abi-Saab D, Pittman B, Chaturvedi SK, Sharma MP, Bell M, Andrade C. Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 492-503. PMID 23093223 DOI: 10.1038/Npp.2012.208 |
0.561 |
|
| 2013 |
Radhakrishnan R, Addy PH, Sewell RA, Skosnik PD, Ranganathan M, D'Souza DC. Cannabis, Cannabinoids, and the Association with Psychosis The Effects of Drug Abuse On the Human Nervous System. 423-474. DOI: 10.1016/B978-0-12-418679-8.00014-9 |
0.678 |
|
| 2012 |
Radhakrishnan R, Menon J, Kanigere M, Ashok M, Shobha V, Galgali RB. Domains and determinants of quality of life in schizophrenia and systemic lupus erythematosus. Indian Journal of Psychological Medicine. 34: 49-55. PMID 22661808 DOI: 10.4103/0253-7176.96159 |
0.313 |
|
| 2012 |
Andrade C, Radhakrishnan R, Fernandes PP. Psychopharmacology of schizophrenia: The Future Looks Bleak. Mens Sana Monographs. 10: 4-12. PMID 22654378 DOI: 10.4103/0973-1229.91293 |
0.367 |
|
| 2012 |
Ranganathan M, Carbuto M, Braley G, Elander J, Perry E, Pittman B, Radhakrishnan R, Sewell RA, D'Souza DC. Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 1251-64. PMID 22243563 DOI: 10.1017/S1461145711001830 |
0.55 |
|
| 2012 |
Ralevski E, Gianoli MO, Russo M, Dwan R, Radhakrishnan R. Cognitive deficits in schizophrenia and alcoholism: A review of the evidence and findings on the effects of treatment on cognitive functioning in patients with dual diagnoses Journal of Dual Diagnosis. 8: 205-217. DOI: 10.1080/15504263.2012.696534 |
0.356 |
|
| 2011 |
Radhakrishnan R, Kanigere M, Menon J, Calvin S, Janish A, Srinivasan K. Association between unconjugated bilirubin and schizophrenia. Psychiatry Research. 189: 480-2. PMID 21470692 DOI: 10.1016/J.Psychres.2011.03.003 |
0.359 |
|
| Show low-probability matches. |